Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab (Q40713858)
Jump to navigation
Jump to search
scientific article published on 16 September 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab |
scientific article published on 16 September 2014 |
Statements
1 reference
Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab (English)
1 reference
Tanja D de Gruijl
1 reference
Saskia Jam Santegoets
1 reference
Anita Gm Stam
1 reference
Sinéad M Lougheed
1 reference
Helen Gall
1 reference
Karin Jooss
1 reference
Natalie Sacks
1 reference
Kristen Hege
1 reference
Israel Lowy
1 reference
Rik J Scheper
1 reference
Winald R Gerritsen
1 reference
Alfons Jm van den Eertwegh
1 reference
16 September 2014
1 reference
1 reference
2
1 reference
31
1 reference
16 September 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference